XSHE
300243
Market cap849mUSD
Oct 09, Last price
18.85CNY
1D
-7.33%
1Q
22.32%
IPO
197.88%
Name
Shandong Ruifeng Chemical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shandong Ruifeng Chemical Co., Ltd. is a Chinese manufacturer and distributor specializing in chemical additives, with a primary focus on products designed for polyvinyl chloride (PVC) applications. The company offers a comprehensive range of chemical solutions, including various impact modifiers (such as acrylic, MBS, PC/ABS, ABS high rubber powder, and ASA high rubber powder), an assortment of PVC processing aids (including acrylic, lubricating, and LS resin types), and PVC lubricants. Beyond these, their product line also encompasses chlorinated polyethylene, PC/ABS resins, epichlorohydrin, and poly butylene adipate-co-terephthalate. While primarily serving the domestic Chinese market, Shandong Ruifeng Chemical also maintains a significant international presence, exporting its goods to key regions like Europe and the United States, as well as to customers throughout South, Southeast, and East Asia. Established in 1994, the company is headquartered in Zibo, China.
Key people
Shibin Zhou
Chairman of the Board · since 2017
Yueling Xu
Chief Financial Officer · since 2016
Yuanyu Qi
Deputy General Manager · since 2025
Jian Wang
Deputy General Manager, Director, Assistant to General Manager · since 2024
Hai Zhou
Deputy General Manager · since 2018
Ziyang Zhao
Secretary of the Board · since 2016
Chunxin Liu
General Manager, Director · since 2017
Zeheng Shao
Director · since 2016
Zhigang Song
Deputy General Manager, Director · since 2016
Chuanxun Tang
Director · since 2009
Yanlong Liu
Independent Director · since 2024
Zhanpeng Wu
Independent Director · since 2023
Suxian Xu
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||